Pediatrix Medical Group I... (MD)

The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.

The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnin...

Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several ...

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value invest...

MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Pediatrix Medical Group (MD). While the effectiveness of this highly sought-after metric is questionab...

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks is more attractive to value ...

Pediatrix Medical's fourth-quarter results reflect a declining overall expense level. It estimates 2025 net income to lie within $98.3-$112.9 million.

Pediatrix Medical Group, Inc. (NYSE:MD ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance & Strategy Mark Ordan - Chief...

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.